Katie Morrison
Lab Manager
As a Laboratory Manager at the Wellcome Trust Centre for Human Genetics, my responsibilities are varied and I am involved in a number of research projects, teaching and administration.
Publications
Ramagopalan SV, Dyment DA, Morrison KM, Herrera BM, Deluca GC, Lincoln MR, Orton SM, Handunnetthi L, Chao MJ, Sadovnick AD, Ebers GC. (2008). Methylation of class II transactivator gene promoter IV is not associated with susceptibility to multiple sclerosis. BMC Med Genet. 9: 63
Ramagopalan SV, Deluca GC, Morrison KM, Herrera BM, Dyment DA, Lincoln MR, Orton SM, Chao MJ, Degenhardt A, Pugliatti M, Sadovnick AD, Sotgiu S, Ebers GC. (2008). Analysis of 45 candidate genes for disease modifying activity in multiple sclerosis. J Neurol. 255: 1215-9
Willer CJ, Dyment DA, Cherny S, Ramagopalan SV, Herrera BM, Morrison KM, Sadovnick AD, Risch NJ, Ebers GC. (2007). A genome-wide scan in forty large pedigrees with multiple sclerosis. J Hum Genet. 52: 955-62
Ramagopalan SV, Deluca GC, Morrison KM, Herrera BM, Dyment DA, Orton S, Bihoreau MT, Degenhardt A, Pugliatti M, Sadovnick AD, Sotgiu S, Ebers GC. (2007) No effect of APOE and PVRL2 on the clinical outcome of multiple sclerosis. J Neuroimmunol. 186: 156-60
Willer CJ, Herrera B, Morrison K, Sadovnick AD, Ebers GC for the Canadian Collaborative Study on Genetic Susceptibility to Multiple Sclerosis (2006). Association between microchimerism and multiple sclerosis in Canadian twins. J Neuroimmunol. 179: 145-151
Dyment DA, Steckley JL, Morrison K, Willer J, Cader MZ, DeLuca GC, Sadovnick AD, Risch N and Ebers GC (2004). TCRB polymorphisms and multiple sclerosis. Genes and Immunity 5: 337-342